Search clinical trials for: Automatic polyp detection system

Total 5002 results

Medical University of Silesia
Centrum Medyczne Andrzej Bożek

Not yet recruiting

Biologics and Sublingual Immunotherapy (BSIPL)

Asthma, Allergic
AstraZeneca

Completed

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study) (HUDSON GI)

Eosinophilic Gastritis | Eosinophilic Gastroenteritis

Italy, Spain, United States, Vietnam, Japan, Netherlands, Ukraine, Poland, Brazil
DEO NV
BeScored Institute

Completed

Comparison Between Automated and Manual Component Impaction in Total Hip Arthroplasty (KINCISE)

Total Hip Arthroplasty (THA)

Belgium
MacroArray Diagnostics GmbH

Completed

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens (MADMAX)

Cat Allergy | Grass Pollen Allergy | Birch Pollen Allergy | House Dust Mite Allergy | Bee Venom Allergy | Vespid Venom Allergy

Austria
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)

Urticaria Chronic

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

Seasonal Allergic Rhinitis

Japan
University of Colorado, Denver
Genentech, Inc.

Completed

Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria

Chronic Urticaria

United States
Novartis Pharmaceuticals

Completed

Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment (SUNRISE)

CHRONIC SPONTANEOUS URTICARIA

France
Johns Hopkins University
Novartis Pharmaceuticals

Completed

Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils

Allergic Asthma

United States
Novartis

Completed

A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy

Asthma

Canada
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Persistent Allergic Asthma

China
National Institute of Allergy and Infectious Diseases...

Completed

ICATA Asthma Mechanistic Study

Asthma

United States
O & O Alpan LLC
Genentech, Inc.

Completed

Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model

Eosinophilic Esophagitis

United States
Novartis
Genentech, Inc.; Tanox

Completed

Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.

Asthma

United States, Argentina, Germany
Medical University of Vienna

Completed

Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients

Atopic Dermatitis

Austria
Pacific Institute for Research and Evaluation
Cephalon

Completed

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders

Alcohol Consumption

United States
Oregon Health and Science University
University of Iowa; Georgia-Pacific Consumer Products LP; RDB Informatics

Recruiting

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System (ESKAPE)

Cross Infection | Surgical Wound Infection

United States
Nantes University Hospital
AstraZeneca; Ministère de la Santé - France

Recruiting

Predictive Signature of Benralizumab Response (BENRAPRED)

Severe Asthma | Asthma; Eosinophilic

France
University of New Mexico
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Immune Dysfunction in Allergic Asthma

Asthma

United States
Asthma Inc Clinical Research Center
University of Washington

Completed

Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria

Chronic Idiopathic Urticaria

United States
Kyowa Kirin Co., Ltd.

Completed

Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis

Eosinophilic Chronic Rhinosinusitis

Japan
Dana-Farber Cancer Institute
Novartis Pharmaceuticals

Completed

Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization

Drug Allergy

United States
Genentech, Inc.

Completed

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing (X-PAND)

Allergic Asthma

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Allergic Asthma

Japan
Ajou University School of Medicine

Unknown

Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients

Asthma
Lynda Schneider

Completed

Xolair Enhances Oral Desensitization in Peanut Allergic Patients

Peanut Allergy

United States
University Hospital, Ghent
Novartis Pharma AG, Switzerland

Completed

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

Asthma | Nasal Polyposis

Belgium
Genentech, Inc.

Completed

A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g

Peanut Hypersensitivity
Fisher and Paykel Healthcare
University Hospital, Angers; University Hospital, Grenoble

Completed

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

Insomnia | Obstructive Sleep Apnea

France
Soroka University Medical Center

Unknown

Inferior Submucosal Turbinectomy Versus Blunt Turbinectomy for Inferior Turbinate Hypertrophy

Bilateral Inferior Turbinates Hypertrophy
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Metabolism Informed Smoking Treatment: The MIST RCT

Smoking

United States
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal (PsiProsper)

Schizophrenia

Portugal
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

The Study of Dachengqi Decoction Combined With Probiotic L92 to Improve the Prognosis of Patients With Severe Abdominal Hypertension

Dachengqi Decoction | Probiotic L92
AstraZeneca

Active, not recruiting

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations (RESOLUTE)

Chronic Obstructive Pulmonary Disease

United States, Austria, Canada, Denmark, Germany, Italy, Spain, United Kingdom, Belgium, Vietnam, Brazil, Hungary, Philippines, China, Korea, Republic of, Argentina, Australia, Poland, Turkey, Japan, Greece, Netherlands, Czechia, Mexico, Bulgar... and more
Boston Children's Hospital
Children's Hospital of Philadelphia; Stanford University; Ann & Robert H Lurie...

Completed

Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial (PRROTECT)

Peanut Allergy | Food Allergy

United States
Assistance Publique - Hôpitaux de Paris

Completed

Individualized Fluid And Vasopressor Administration In Surgical Patients (INFIVASP)

Intraoperative Hypotension

France
Novartis Pharmaceuticals

Completed

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

Chronic Spontaneous Urticaria

United States, Spain, United Kingdom, Germany, Taiwan, Japan, Australia, Greece, Russian Federation, Canada
University of California, San Francisco
University of Chicago

Withdrawn

Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis

Chronic Sinusitis
Genentech, Inc.
Novartis

Completed

An Observational Study of the Use and Safety of Xolair® During Pregnancy (EXPECT)

Asthma

United States
AiCure
Montefiore Medical Center; Orexo AB

Completed

Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy

Addiction | Opioid Dependence | Opiate Addiction | Medication Non-adherence

United States
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Omalizumab in the Treatment of Peanut Allergy

Peanut Allergy | Food Allergy

United States
Genentech, Inc.

Completed

A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)

Asthma
University of North Carolina, Chapel Hill
Genentech, Inc.; National Institutes of Health (NIH)

Terminated

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

Asthma | Allergy

United States
ASST Gaetano Pini-CTO

Completed

Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus

Injury of Anterior Cruciate Ligament

Italy
National Cancer Institute (NCI)

Completed

Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers

Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Endoscopic Therapy of Early Cancer in Barretts Esophagus

Barrett Esophagus | Early Stage Esophageal Adenocarcinoma

United States
Henry Ford Health System

Recruiting

Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation

Engraftment Syndrome

United States
Stratejik Yenilikci Girisimler Ltd.
Haseki Sultangazi Teaching and Research Hospital, University of Health Sciences

Completed

Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV)

Benign Paroxysmal Positional Vertigo

Turkey
Medtrum France
Axonal-Biostatem

Recruiting

Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System (SEECLOOP)

Type 1 Diabetes

France
AAADRS Clinical Research Center

Recruiting

FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA

Food Allergy

United States

Search clinical trials for: Automatic polyp detection system

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations